Gamelin Erick insider trades
Gamelin Erick has filed 17 Form 4s with the SEC that we hold, all for Acrivon Therapeutics, Inc. (ACRV), as Chief Development Officer. Across all of them we count 0 purchases worth $0 and 1 sale worth $804 reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($804). The largest single trade was a sale of 400 shares of Acrivon Therapeutics, Inc. worth $804, dated 2026-08-18. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-11-16 and the latest 2026-08-20.
Acrivon Therapeutics, Inc. (ACRV)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-08-18 | S, sale reported on Form 4 | 400 | $804 | 2026-08-20 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1950551) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms